Autochthon Biotechnology

April 2012. April 2012. In order to turn algal biomass into a commodity product current cost is to be significantly brought down. Dr James Flatt, CTO of Synthetic Genomics provides in-depth answers to probing questions by B2Bioworld about SGI’s R&D strategies, its business case, social responsibility and returns to investors – including Agradis and developing countriesReading time: 12 min

Read Now:
1,00 EUR (incl. 7% VAT)

Back to section